BIOMARIN PHARMACEUTICAL INC
Pharmaceutical Preparations · 105 DIGITAL DRIVE, NOVATO, CA 94949
官方登記資料
0位追蹤者
1997成立於
關於 BIOMARIN PHARMACEUTICAL INC
BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research are in enzyme replacement therapies (ERTs). BioMarin was the first company to provide therapeutics for mucopolysaccharidosis type I, by manufacturing laronidase. BioMarin was also the first company to provide therapeutics for phenylketonuria (PKU).
Source: Wikipedia
產業Pharmaceutical Preparations
總部105 DIGITAL DRIVE, NOVATO, CA 94949
成立時間1997
法律形式C Corporation
狀態營運中
專利36 項專利
METHODS FOR TREATING CLN2 DISEASE IN PEDIATRIC SUBJECTSJP2025165414A · 2025
CNP VARIANTS AND CONJUGATES THEREOFJP2025162558A · 2025
關鍵數據
法律資訊
| 法定名稱 | BIOMARIN PHARMACEUTICAL INC |
|---|---|
| 法律形式 | C Corporation |
| SEC CIK | 1048477在 SEC EDGAR 上查看 ↗ |
| EIN | 68-0397820 |
| 產業代碼(SIC) | 2834 |
| 登記地址 | 105 DIGITAL DRIVE, NOVATO, CA 94949 |
| 狀態 | 營運中 |
來源: SEC EDGAR · 更新於 2026年10月15日